SPX4,026.12-1.14 -0.03%
DIA343.52+1.57 0.46%
IXIC11,226.36-58.96 -0.52%

RBC Capital Initiates Coverage On Mind Medicine with Outperform Rating, Announces Price Target of $5

Benzinga · 11/16/2022 06:10
RBC Capital analyst Brian Abrahams initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Outperform rating and announces Price Target of $5.